FDAnews Device Daily Bulletin

BOSTON SCI STILL INTERESTED IN GUIDANT, DESPITE SETBACKS

Dec. 19, 2005
A A

A day after Guidant confirmed that three additional deaths have been attributed to models of recalled heart defibrillators, the company's potential buyer, Boston Scientific, said it still believes in the underlying strength of Guidant's businesses. Indianapolis-based Guidant, whose cardiac rhythm management division is based in Arden Hills, said a total of seven deaths have been attributed to models of implantable cardioverter defibrillators that were recalled because of safety concerns.
Star Tribune